Guo Liwei, An Yong, Huang Xu, Liu Wenhua, Chen Fangfang, Fan Yuchen, Gao Shuai, Han Liyan, Wang Kai
Medical Integration and Practice Center, Shandong University, Jinan, Shandong, China.
Department of Epidemiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
Front Med (Lausanne). 2024 May 22;11:1390049. doi: 10.3389/fmed.2024.1390049. eCollection 2024.
Liver fibrosis significantly impacts public health globally. Untreated liver fibrosis eventually results in cirrhosis. Cigarette smoking is the main etiologic factor for various diseases. However, the causal effects of cigarette smoking on liver fibrosis and cirrhosis have yet to be fully elucidated.
In this study, Mendelian randomization (MR) analysis was performed to assess the association between cigarette smoking, liver fibrosis, and cirrhosis. Single-nucleotide polymorphisms (SNPs) were selected as instrumental variables from a genome-wide association study (GWAS) of European ancestry. Patients were divided into six exposure categories as follows: "ever smoked," "pack years of smoking," "age of smoking initiation," "smoking status: never," "smoking status: current," and "smoking status: previous." The outcomes of this study included liver fibrosis and cirrhosis. MR-Egger, weighted median, inverse variance weighted, simple mode, and weighted mode were selected as the analysis methods. Cochran's Q and the MR-PRESSO tests were conducted to measure heterogeneity. The MR-Egger method was performed to evaluate horizontal pleiotropy, while the "leave-one-out" analysis was performed for sensitivity testing.
The results of this study showed that having a smoking history increases the risk of liver fibrosis and cirrhosis ["ever smoked": odds ratio (OR) = 5.704, 95% CI: 1.166-27.910, = 0.032; "smoking status: previous": OR = 99.783, 95% CI: 2.969-3.353e+03, = 0.010]. A negative correlation was observed between patients who never smoked and liver fibrosis and cirrhosis ("smoking status: never": OR = 0.171, 95% CI: 0.041-0.719, = 0.016). However, there were no significant associations between "smoking status: current," "pack years of smoking," and "age of smoking initiation" and liver fibrosis and cirrhosis. Cigarette smoking did not have a significant horizontal pleiotropic effect on liver fibrosis and cirrhosis. The "Leave-one-out" sensitivity analysis indicated that the results were stable.
The study confirmed the causal effects of cigarette smoking on liver fibrosis and cirrhosis.
肝纤维化对全球公众健康有重大影响。未经治疗的肝纤维化最终会导致肝硬化。吸烟是多种疾病的主要病因。然而,吸烟对肝纤维化和肝硬化的因果关系尚未完全阐明。
在本研究中,进行了孟德尔随机化(MR)分析,以评估吸烟、肝纤维化和肝硬化之间的关联。单核苷酸多态性(SNP)作为工具变量,从欧洲血统的全基因组关联研究(GWAS)中选取。患者被分为以下六个暴露类别:“曾经吸烟”、“吸烟包年数”、“开始吸烟年龄”、“吸烟状态:从不”、“吸烟状态:当前”和“吸烟状态:既往曾经吸烟”。本研究的结局包括肝纤维化和肝硬化。选取MR-Egger、加权中位数、逆方差加权、简单模式和加权模式作为分析方法。进行Cochran's Q检验和MR-PRESSO检验以衡量异质性。采用MR-Egger方法评估水平多效性,同时进行“留一法”分析以进行敏感性检验。
本研究结果表明,有吸烟史会增加肝纤维化和肝硬化的风险(“曾经吸烟”:比值比(OR)=5.704,95%置信区间:1.166-27.910,P=0.032;“吸烟状态:既往曾经吸烟”:OR=99.783,95%置信区间:2.969-3.353×10³,P=0.010)。从未吸烟的患者与肝纤维化和肝硬化之间存在负相关(“吸烟状态:从不”:OR=0.171,95%置信区间:0.041-0.719,P=0.016)。然而,“吸烟状态:当前”、“吸烟包年数”和“开始吸烟年龄”与肝纤维化和肝硬化之间无显著关联。吸烟对肝纤维化和肝硬化没有显著的水平多效性影响。“留一法”敏感性分析表明结果稳定。
该研究证实了吸烟对肝纤维化和肝硬化的因果关系。